...
首页> 外文期刊>BMC Medical Informatics and Decision Making >A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network
【24h】

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

机译:基于长短期记忆神经网络的药物 - 目标交互预测基于深度学习的方法

获取原文
           

摘要

The key to modern drug discovery is to find, identify and prepare drug molecular targets. However, due to the influence of throughput, precision and cost, traditional experimental methods are difficult to be widely used to infer these potential Drug-Target Interactions (DTIs). Therefore, it is urgent to develop effective computational methods to validate the interaction between drugs and target. We developed a deep learning-based model for DTIs prediction. The proteins evolutionary features are extracted via Position Specific Scoring Matrix (PSSM) and Legendre Moment (LM) and associated with drugs molecular substructure fingerprints to form feature vectors of drug-target pairs. Then we utilized the Sparse Principal Component Analysis (SPCA) to compress the features of drugs and proteins into a uniform vector space. Lastly, the deep long short-term memory (DeepLSTM) was constructed for carrying out prediction. A significant improvement in DTIs prediction performance can be observed on experimental results, with AUC of 0.9951, 0.9705, 0.9951, 0.9206, respectively, on four classes important drug-target datasets. Further experiments preliminary proves that the proposed characterization scheme has great advantage on feature expression and recognition. We also have shown that the proposed method can work well with small dataset. The results demonstration that the proposed approach has a great advantage over state-of-the-art drug-target predictor. To the best of our knowledge, this study first tests the potential of deep learning method with memory and Turing completeness in DTIs prediction.
机译:现代药物发现的关键是找到,识别和制备药物分子靶标。然而,由于产量,精度和成本的影响,传统的实验方法难以广泛用于推断这些潜在的药物靶标相互作用(DTI)。因此,迫切需要开发有效的计算方法来验证药物和目标之间的相互作用。我们开发了一种基于深度学习的DTI预测模型。通过位置特异性评分基质(PSSM)和LegendRe时刻(LM)提取蛋白质进化特征,并与药物分子亚结构指纹相关联,以形成药物 - 靶对的特征载体。然后我们利用稀疏的主成分分析(SPCA)将药物和蛋白质的特征压缩成均匀的矢量空间。最后,构建了深度长的短期记忆(DEEPLSTM)以进行预测。可以在实验结果上观察到DTI预测性能的显着改善,AUC为0.9951,0.9705,0.9951,0.9206,在四个类别的重要药物 - 目标数据集中。进一步的实验初步证明,所提出的表征方案对特征表达和识别具有很大的优势。我们还表明,所提出的方法可以很好地使用小型数据集。结果表明,拟议的方法具有与最先进的药物目标预测因子具有很大的优势。据我们所知,本研究首先测试了DTI预测中的内存和图灵完整性的深度学习方法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号